These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 35179708)
1. Venous Thrombotic Events and Anticoagulation in Brain Tumor Patients. Diaz M; Jo J Curr Oncol Rep; 2022 Apr; 24(4):493-500. PubMed ID: 35179708 [TBL] [Abstract][Full Text] [Related]
2. Intracranial hemorrhage with direct oral anticoagulants in patients with brain tumors. Carney BJ; Uhlmann EJ; Puligandla M; Mantia C; Weber GM; Neuberg DS; Zwicker JI J Thromb Haemost; 2019 Jan; 17(1):72-76. PubMed ID: 30450803 [TBL] [Abstract][Full Text] [Related]
3. Risk of intracranial hemorrhage with direct oral anticoagulation versus low molecular weight heparin in the treatment of brain tumor-associated venous thromboembolism: A meta-analysis. Yang J; He Z; Li M; Hong T; Ouyang T J Stroke Cerebrovasc Dis; 2023 Aug; 32(8):107243. PubMed ID: 37413715 [TBL] [Abstract][Full Text] [Related]
4. Safety of Direct Oral Anticoagulants in Central Nervous System Malignancies. Swartz AW; Drappatz J Oncologist; 2021 May; 26(5):427-432. PubMed ID: 33523555 [TBL] [Abstract][Full Text] [Related]
5. Vascular complications in patients with brain tumors. Diaz M; Schiff D Curr Opin Oncol; 2022 Nov; 34(6):698-704. PubMed ID: 35788556 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic Anticoagulation in Patients with Primary Brain Tumors or Secondary Brain Metastasis. Lin RJ; Green DL; Shah GL Oncologist; 2018 Apr; 23(4):468-473. PubMed ID: 29158366 [TBL] [Abstract][Full Text] [Related]
7. Risk of intracranial hemorrhage associated with therapeutic anticoagulation for venous thromboembolism in cancer patients: a systematic review and meta-analysis. Rojas-Hernandez CM; Oo TH; García-Perdomo HA J Thromb Thrombolysis; 2017 Feb; 43(2):233-240. PubMed ID: 27704333 [TBL] [Abstract][Full Text] [Related]
8. Anticoagulation in the Setting of Primary and Metastatic Brain Tumors. Mantia C; Zwicker JI Cancer Treat Res; 2019; 179():179-189. PubMed ID: 31317488 [TBL] [Abstract][Full Text] [Related]
9. Risk of intracranial bleeding in patients with primary brain cancer receiving therapeutic anticoagulation for venous thromboembolism: A meta-analysis. Porfidia A; Giordano M; Sturiale CL; D'Arrigo S; Donadini MP; Olivi A; Ageno W; Pola R Brain Behav; 2020 Jun; 10(6):e01638. PubMed ID: 32314875 [TBL] [Abstract][Full Text] [Related]
10. Intracranial hemorrhage in cancer patients treated with anticoagulation. Weinstock MJ; Uhlmann EJ; Zwicker JI Thromb Res; 2016 Apr; 140 Suppl 1():S60-5. PubMed ID: 27067980 [TBL] [Abstract][Full Text] [Related]
11. Comparison of direct oral anticoagulants versus low-molecular-weight heparin in primary and metastatic brain cancers: a meta-analysis and systematic review. Iyengar V; Agrawal S; Chiasakul T; Tehranchi K; Mcnichol M; Carney BJ; Leader A; Zwicker JI; Patell R J Thromb Haemost; 2024 Feb; 22(2):423-429. PubMed ID: 37866517 [TBL] [Abstract][Full Text] [Related]
12. Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism. Giustozzi M; Franco L; Vedovati MC; Becattini C; Agnelli G J Thromb Thrombolysis; 2019 Oct; 48(3):439-453. PubMed ID: 31104194 [TBL] [Abstract][Full Text] [Related]
13. Risk of intracranial hemorrhage with direct oral anticoagulants vs low molecular weight heparin in glioblastoma: A retrospective cohort study. Reed-Guy L; Desai AS; Phillips RE; Croteau D; Albright K; O'Neill M; Brem S; O'Rourke DM; Amankulor NM; Bagley SJ Neuro Oncol; 2022 Dec; 24(12):2172-2179. PubMed ID: 35551405 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic anticoagulation for venous thromboembolism after recent brain surgery: Evaluating the risk of intracranial hemorrhage. de Melo Junior JO; Lodi Campos Melo MA; da Silva Lavradas LA; Ferreira Lopes PG; Luiz Ornelas II; de Barros PL; da Mata Pereira PJ; Niemeyer Filho P Clin Neurol Neurosurg; 2020 Oct; 197():106202. PubMed ID: 32916398 [TBL] [Abstract][Full Text] [Related]
15. Epidemiology, biology, and management of venous thromboembolism in gliomas: An interdisciplinary review. Jo J; Diaz M; Horbinski C; Mackman N; Bagley S; Broekman M; Rak J; Perry J; Pabinger I; Key NS; Schiff D Neuro Oncol; 2023 Aug; 25(8):1381-1394. PubMed ID: 37100086 [TBL] [Abstract][Full Text] [Related]
16. Comparative effectiveness and safety of direct oral anticoagulants (DOACs) versus conventional anticoagulation for the treatment of cancer-related venous thromboembolism: A retrospective analysis. Ross JA; Miller MM; Rojas Hernandez CM Thromb Res; 2017 Feb; 150():86-89. PubMed ID: 28064037 [TBL] [Abstract][Full Text] [Related]
17. Outcomes of low-molecular-weight heparin treatment for venous thromboembolism in patients with primary and metastatic brain tumours. Chai-Adisaksopha C; Linkins LA; ALKindi SY; Cheah M; Crowther MA; Iorio A Thromb Haemost; 2017 Feb; 117(3):589-594. PubMed ID: 28078351 [TBL] [Abstract][Full Text] [Related]
18. Management of venous thromboembolism in high-grade glioma: Does low molecular weight heparin increase intracranial bleeding risk? Jo J; Donahue J; Sarai G; Petroni G; Schiff D Neuro Oncol; 2022 Mar; 24(3):455-464. PubMed ID: 34383073 [TBL] [Abstract][Full Text] [Related]
19. Venous thrombosis in patients with high-grade glioma. Taillibert S; Taillandier L; Le Rhun E Curr Opin Oncol; 2015 Nov; 27(6):516-21. PubMed ID: 26447877 [TBL] [Abstract][Full Text] [Related]
20. Network meta-analysis of anticoagulation strategies for venous thromboembolism in patients with cancer. Ueyama H; Miyashita H; Takagi H; Cruz C; Burger A; Briasoulis A; Kuno T J Thromb Thrombolysis; 2021 Jan; 51(1):102-111. PubMed ID: 32458316 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]